|
US2524855A
(en)
|
|
1950-10-10 |
|
Process for the manufacture of |
|
CA722109A
(en)
|
|
1965-11-23 |
W. Mock Henry |
Extrusion of ethylene oxide polymers
|
|
DE446470C
(de)
*
|
1926-01-08 |
1927-06-28 |
Reichelt Fa H |
Drehbarer Trommelrechen
|
|
US2806033A
(en)
|
1955-08-03 |
1957-09-10 |
Lewenstein |
Morphine derivative
|
|
US2987445A
(en)
|
1958-10-10 |
1961-06-06 |
Rohm & Haas |
Drug composition
|
|
US3370035A
(en)
|
1961-06-23 |
1968-02-20 |
Takeda Chemical Industries Ltd |
Stabilization of polyalkylene oxide
|
|
US3332950A
(en)
|
1963-03-23 |
1967-07-25 |
Endo Lab |
14-hydroxydihydronormorphinone derivatives
|
|
GB1147210A
(en)
|
1965-06-30 |
1969-04-02 |
Eastman Kodak Co |
Improvements in or relating to vitamins
|
|
US3652589A
(en)
|
1967-07-27 |
1972-03-28 |
Gruenenthal Chemie |
1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
|
|
US3806603A
(en)
|
1969-10-13 |
1974-04-23 |
W Gaunt |
Pharmaceutical carriers of plasticized dried milled particles of hydrated cooked rice endosperm
|
|
DE2210071A1
(de)
|
1971-03-09 |
1972-09-14 |
PPG Industries Inc., Pittsburgh, Pa. (V.StA.) |
Verfahren zum Auftragen und Härten einer Vielzahl von Überzügen
|
|
US3865108A
(en)
|
1971-05-17 |
1975-02-11 |
Ortho Pharma Corp |
Expandable drug delivery device
|
|
US3966747A
(en)
|
1972-10-26 |
1976-06-29 |
Bristol-Myers Company |
9-Hydroxy-6,7-benzomorphans
|
|
US4014965A
(en)
|
1972-11-24 |
1977-03-29 |
The Dow Chemical Company |
Process for scrapless forming of plastic articles
|
|
US3980766A
(en)
|
1973-08-13 |
1976-09-14 |
West Laboratories, Inc. |
Orally administered drug composition for therapy in the treatment of narcotic drug addiction
|
|
US3941865A
(en)
|
1973-12-10 |
1976-03-02 |
Union Carbide Corporation |
Extrusion of ethylene oxide resins
|
|
US4002173A
(en)
|
1974-07-23 |
1977-01-11 |
International Paper Company |
Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
|
|
DE2530563C2
(de)
|
1975-07-09 |
1986-07-24 |
Bayer Ag, 5090 Leverkusen |
Analgetische Arzneimittel mit vermindertem Mißbrauchspotential
|
|
JPS603286B2
(ja)
|
1977-03-03 |
1985-01-26 |
日本化薬株式会社 |
定速溶出性製剤
|
|
US4207893A
(en)
|
1977-08-29 |
1980-06-17 |
Alza Corporation |
Device using hydrophilic polymer for delivering drug to biological environment
|
|
US4175119A
(en)
|
1978-01-11 |
1979-11-20 |
Porter Garry L |
Composition and method to prevent accidental and intentional overdosage with psychoactive drugs
|
|
DE2822324C3
(de)
|
1978-05-22 |
1981-02-26 |
Basf Ag, 6700 Ludwigshafen |
Herstellung von Vitamin-E-Trockenpulver
|
|
US4211681A
(en)
|
1978-08-16 |
1980-07-08 |
Union Carbide Corporation |
Poly(ethylene oxide) compositions
|
|
US4200704A
(en)
|
1978-09-28 |
1980-04-29 |
Union Carbide Corporation |
Controlled degradation of poly(ethylene oxide)
|
|
NO793297L
(no)
|
1978-10-19 |
1980-04-22 |
Mallinckrodt Inc |
Fremgangsmaate til fremstilling av oksymorfon
|
|
US4215104A
(en)
|
1979-03-26 |
1980-07-29 |
Mead Johnson & Company |
Multi-fractionable tablet structure
|
|
US4258027A
(en)
|
1979-03-26 |
1981-03-24 |
Mead Johnson & Company |
Multi-fractionable tablet structure
|
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
|
US4353887A
(en)
|
1979-08-16 |
1982-10-12 |
Ciba-Geigy Corporation |
Divisible tablet having controlled and delayed release of the active substance
|
|
CH648754A5
(en)
|
1979-08-16 |
1985-04-15 |
Ciba Geigy Ag |
Pharmaceutical slow release tablet
|
|
US4457933A
(en)
*
|
1980-01-24 |
1984-07-03 |
Bristol-Myers Company |
Prevention of analgesic abuse
|
|
JPS56169622A
(en)
|
1980-06-03 |
1981-12-26 |
Kissei Pharmaceut Co Ltd |
Method of making solid preparation from oily substance
|
|
DE3024416C2
(de)
*
|
1980-06-28 |
1982-04-15 |
Gödecke AG, 1000 Berlin |
Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
|
|
US4473640A
(en)
|
1982-06-03 |
1984-09-25 |
Combie Joan D |
Detection of morphine and its analogues using enzymatic hydrolysis
|
|
US4462941A
(en)
|
1982-06-10 |
1984-07-31 |
The Regents Of The University Of California |
Dynorphin amide analogs
|
|
US4427778A
(en)
|
1982-06-29 |
1984-01-24 |
Biochem Technology, Inc. |
Enzymatic preparation of particulate cellulose for tablet making
|
|
US4485211A
(en)
*
|
1982-09-15 |
1984-11-27 |
The B. F. Goodrich Company |
Poly(glycidyl ether)block copolymers and process for their preparation
|
|
US4427681A
(en)
|
1982-09-16 |
1984-01-24 |
Richardson-Vicks, Inc. |
Thixotropic compositions easily convertible to pourable liquids
|
|
US4529583A
(en)
|
1983-03-07 |
1985-07-16 |
Clear Lake Development Group |
Composition and method of immobilizing emetics and method of treating human beings with emetics
|
|
US4603143A
(en)
|
1983-05-02 |
1986-07-29 |
Basf Corporation |
Free-flowing, high density, fat soluble vitamin powders with improved stability
|
|
US4765989A
(en)
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
|
US4612008A
(en)
|
1983-05-11 |
1986-09-16 |
Alza Corporation |
Osmotic device with dual thermodynamic activity
|
|
US5082668A
(en)
*
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
|
US4783337A
(en)
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
|
US4599342A
(en)
|
1984-01-16 |
1986-07-08 |
The Procter & Gamble Company |
Pharmaceutical products providing enhanced analgesia
|
|
US4629621A
(en)
|
1984-07-23 |
1986-12-16 |
Zetachron, Inc. |
Erodible matrix for sustained release bioactive composition
|
|
AU592065B2
(en)
|
1984-10-09 |
1990-01-04 |
Dow Chemical Company, The |
Sustained release dosage form based on highly plasticized cellulose ether gels
|
|
GB8507779D0
(en)
|
1985-03-26 |
1985-05-01 |
Fujisawa Pharmaceutical Co |
Drug carrier
|
|
WO1987000045A1
(en)
|
1985-06-24 |
1987-01-15 |
Ici Australia Limited |
Ingestible capsules
|
|
AU607681B2
(en)
|
1985-06-28 |
1991-03-14 |
Carrington Laboratories, Inc. |
Processes for preparation of aloe products, products produced thereby and compositions thereof
|
|
US4992279A
(en)
|
1985-07-03 |
1991-02-12 |
Kraft General Foods, Inc. |
Sweetness inhibitor
|
|
US4851521A
(en)
|
1985-07-08 |
1989-07-25 |
Fidia, S.P.A. |
Esters of hyaluronic acid
|
|
EP0226061B1
(en)
|
1985-12-17 |
1994-02-16 |
United States Surgical Corporation |
High molecular weight bioresorbable polymers and implantation devices thereof
|
|
US5229164A
(en)
|
1985-12-19 |
1993-07-20 |
Capsoid Pharma Gmbh |
Process for producing individually dosed administration forms
|
|
US4711894A
(en)
|
1986-01-16 |
1987-12-08 |
Henkel Corporation |
Stabilized tocopherol in dry, particulate, free-flowing form
|
|
US4940556A
(en)
*
|
1986-01-30 |
1990-07-10 |
Syntex (U.S.A.) Inc. |
Method of preparing long acting formulation
|
|
US5198226A
(en)
*
|
1986-01-30 |
1993-03-30 |
Syntex (U.S.A.) Inc. |
Long acting nicardipine hydrochloride formulation
|
|
US4764378A
(en)
|
1986-02-10 |
1988-08-16 |
Zetachron, Inc. |
Buccal drug dosage form
|
|
BR8701434A
(pt)
|
1986-03-31 |
1987-12-29 |
Union Carbide Corp |
Processo para a producao de uma dispersao,processo para a producao de um catalisador;processo para a producao de oxidos de polialquileno;e processo para a producao de polimeros solidos de oxido de alquileno em condicoes de pressao relativamente baixas
|
|
DE3612211A1
(de)
|
1986-04-11 |
1987-10-15 |
Basf Ag |
Kontinuierliches verfahren zum tablettieren
|
|
US4667013A
(en)
*
|
1986-05-02 |
1987-05-19 |
Union Carbide Corporation |
Process for alkylene oxide polymerization
|
|
US4713243A
(en)
|
1986-06-16 |
1987-12-15 |
Johnson & Johnson Products, Inc. |
Bioadhesive extruded film for intra-oral drug delivery and process
|
|
USRE33093E
(en)
|
1986-06-16 |
1989-10-17 |
Johnson & Johnson Consumer Products, Inc. |
Bioadhesive extruded film for intra-oral drug delivery and process
|
|
USRE34990E
(en)
|
1986-08-07 |
1995-07-04 |
Ciba-Geigy Corporation |
Oral therapeutic system having systemic action
|
|
CA1335748C
(en)
|
1986-09-25 |
1995-05-30 |
Jeffrey Lawrence Finnan |
Crosslinked gelatins
|
|
US5227157A
(en)
|
1986-10-14 |
1993-07-13 |
Board Of Regents, The University Of Texas System |
Delivery of therapeutic agents
|
|
JP2962731B2
(ja)
|
1986-11-10 |
1999-10-12 |
バイオピュアー、コーポレーション |
超純枠半合成代用血液
|
|
US4892889A
(en)
|
1986-11-18 |
1990-01-09 |
Basf Corporation |
Process for making a spray-dried, directly-compressible vitamin powder comprising unhydrolyzed gelatin
|
|
JPH0831303B2
(ja)
|
1986-12-01 |
1996-03-27 |
オムロン株式会社 |
チツプ型ヒユ−ズ
|
|
DE3868077D1
(de)
*
|
1987-01-14 |
1992-03-12 |
Ciba Geigy Ag |
Therapeutisches system fuer schwerloesliche wirkstoffe.
|
|
US4892778A
(en)
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
|
US5051261A
(en)
|
1987-11-24 |
1991-09-24 |
Fmc Corporation |
Method for preparing a solid sustained release form of a functionally active composition
|
|
AU611520B2
(en)
|
1987-12-17 |
1991-06-13 |
Pharmacia & Upjohn Company Llc |
Tri-scored drug tablet
|
|
DE3812567A1
(de)
|
1988-04-15 |
1989-10-26 |
Basf Ag |
Verfahren zur herstellung pharmazeutischer mischungen
|
|
US4954346A
(en)
|
1988-06-08 |
1990-09-04 |
Ciba-Geigy Corporation |
Orally administrable nifedipine solution in a solid light resistant dosage form
|
|
US4960814A
(en)
|
1988-06-13 |
1990-10-02 |
Eastman Kodak Company |
Water-dispersible polymeric compositions
|
|
US5350741A
(en)
|
1988-07-30 |
1994-09-27 |
Kanji Takada |
Enteric formulations of physiologically active peptides and proteins
|
|
JPH0249719A
(ja)
|
1988-08-11 |
1990-02-20 |
Dai Ichi Kogyo Seiyaku Co Ltd |
易水分散・可溶性能を有する油溶性ビタミン粉末
|
|
GB8820327D0
(en)
|
1988-08-26 |
1988-09-28 |
May & Baker Ltd |
New compositions of matter
|
|
DE3830353A1
(de)
*
|
1988-09-07 |
1990-03-15 |
Basf Ag |
Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
|
|
US5139790A
(en)
*
|
1988-10-14 |
1992-08-18 |
Zetachron, Inc. |
Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
|
|
US5004601A
(en)
|
1988-10-14 |
1991-04-02 |
Zetachron, Inc. |
Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
|
|
US4957668A
(en)
|
1988-12-07 |
1990-09-18 |
General Motors Corporation |
Ultrasonic compacting and bonding particles
|
|
US5190760A
(en)
|
1989-07-08 |
1993-03-02 |
Coopers Animal Health Limited |
Solid pharmaceutical composition
|
|
US5169645A
(en)
|
1989-10-31 |
1992-12-08 |
Duquesne University Of The Holy Ghost |
Directly compressible granules having improved flow properties
|
|
US5200197A
(en)
|
1989-11-16 |
1993-04-06 |
Alza Corporation |
Contraceptive pill
|
|
GB8926612D0
(en)
|
1989-11-24 |
1990-01-17 |
Erba Farmitalia |
Pharmaceutical compositions
|
|
EP0449775A3
(en)
*
|
1990-03-29 |
1992-09-02 |
Ciba-Geigy Ag |
Polyether-polyester block copolymers and their use as dispersing agents
|
|
SU1759445A1
(ru)
|
1990-06-15 |
1992-09-07 |
Ленинградский Технологический Институт Им.Ленсовета |
Способ получени капсулированных гидрофобных веществ
|
|
FR2664851B1
(fr)
|
1990-07-20 |
1992-10-16 |
Oreal |
Procede de compactage d'un melange pulverulent permettant d'obtenir un produit compact absorbant ou partiellement delitable et produit obtenu par ce procede.
|
|
EP0477135A1
(en)
|
1990-09-07 |
1992-03-25 |
Warner-Lambert Company |
Chewable spheroidal coated microcapsules and methods for preparing same
|
|
US5126151A
(en)
*
|
1991-01-24 |
1992-06-30 |
Warner-Lambert Company |
Encapsulation matrix
|
|
US5273758A
(en)
|
1991-03-18 |
1993-12-28 |
Sandoz Ltd. |
Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
|
|
US5149538A
(en)
|
1991-06-14 |
1992-09-22 |
Warner-Lambert Company |
Misuse-resistive transdermal opioid dosage form
|
|
JP3073054B2
(ja)
|
1991-07-11 |
2000-08-07 |
住友精化株式会社 |
アルキレンオキシド重合体の製造方法
|
|
US5496563A
(en)
|
1991-08-30 |
1996-03-05 |
Showa Yakuhin Kako Co., Ltd. |
Dry gel composition
|
|
AU2670292A
(en)
|
1991-10-04 |
1993-05-03 |
Olin Corporation |
Fungicide tablet
|
|
ATE183642T1
(de)
|
1991-10-04 |
1999-09-15 |
Yoshitomi Pharmaceutical |
Tablette mit verzögerter freisetzung
|
|
DE4138513A1
(de)
|
1991-11-23 |
1993-05-27 |
Basf Ag |
Feste pharmazeutische retardform
|
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
ES2090714T3
(es)
|
1991-12-05 |
1996-10-16 |
Mallinckrodt Veterinary Inc |
Matriz de vidrio de carbohidrato para la liberacion prolongada de un agente terapeutico.
|
|
DK0617612T3
(da)
|
1991-12-18 |
1998-04-14 |
Warner Lambert Co |
Fremgangsmåde til fremstilling af en fast dispersion
|
|
US5225417A
(en)
|
1992-01-21 |
1993-07-06 |
G. D. Searle & Co. |
Opioid agonist compounds
|
|
IL105553A
(en)
|
1992-05-06 |
1998-01-04 |
Janssen Pharmaceutica Inc |
Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
|
|
ES2086229T3
(es)
|
1992-05-22 |
1996-06-16 |
Goedecke Ag |
Procedimiento para la obtencion de preparados medicinales de accion retardada.
|
|
GB9217295D0
(en)
*
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
|
DE4227385A1
(de)
|
1992-08-19 |
1994-02-24 |
Kali Chemie Pharma Gmbh |
Pankreatinmikropellets
|
|
DE4229085C2
(de)
*
|
1992-09-01 |
1996-07-11 |
Boehringer Mannheim Gmbh |
Längliche, teilbare Tablette
|
|
PT661045E
(pt)
|
1992-09-18 |
2002-11-29 |
Yamanouchi Pharma Co Ltd |
Preparacao em hidrogel de libertacao prolongada
|
|
US5472943A
(en)
*
|
1992-09-21 |
1995-12-05 |
Albert Einstein College Of Medicine Of Yeshiva University, |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists
|
|
FI101039B
(fi)
|
1992-10-09 |
1998-04-15 |
Eeva Kristoffersson |
Menetelmä lääkepellettien valmistamiseksi
|
|
AU679937B2
(en)
|
1992-11-18 |
1997-07-17 |
Johnson & Johnson Consumer Products, Inc. |
Extrudable compositions for topical or transdermal drug delivery
|
|
US5662935A
(en)
|
1992-12-23 |
1997-09-02 |
Saitec S.R.L. |
Process for preparing controlled release pharmaceutical forms and the forms thus obtained
|
|
GB2273874A
(en)
|
1992-12-31 |
1994-07-06 |
Pertti Olavi Toermaelae |
Preparation of pharmaceuticals in a polymer matrix
|
|
US6071970A
(en)
|
1993-02-08 |
2000-06-06 |
Nps Pharmaceuticals, Inc. |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
|
|
US5914132A
(en)
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
DE4309528C2
(de)
|
1993-03-24 |
1998-05-20 |
Doxa Gmbh |
Folie oder Folienschlauch aus Casein, Verfahren zu deren Herstellung und deren Verwendung
|
|
NZ260408A
(en)
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
|
IL109944A
(en)
|
1993-07-01 |
1998-12-06 |
Euro Celtique Sa |
Continuous release dosage form containing morphine and a method of preparing such sustained release unit dosage forms
|
|
DE4329794C2
(de)
|
1993-09-03 |
1997-09-18 |
Gruenenthal Gmbh |
Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
|
|
HU218673B
(hu)
|
1993-10-07 |
2000-10-28 |
Euroceltique S.A. |
Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására
|
|
KR100354702B1
(ko)
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
|
ATE212224T1
(de)
|
1993-11-23 |
2002-02-15 |
Euro Celtique Sa |
Verfahren zur herstellung einer arzneizusammensetzung mit verzögerter wirkstoffabgabe
|
|
WO1995017174A1
(en)
|
1993-12-20 |
1995-06-29 |
The Procter & Gamble Company |
Process for making laxatives containing dioctyl sulfosuccinate
|
|
IL112106A0
(en)
|
1993-12-22 |
1995-03-15 |
Ergo Science Inc |
Accelerated release composition containing bromocriptine
|
|
GB9401894D0
(en)
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
|
ES2199981T3
(es)
|
1994-02-16 |
2004-03-01 |
Abbott Laboratories |
Modo de preparacion de formulaciones farmaceuticas de particulas finas.
|
|
SE9503924D0
(sv)
|
1995-08-18 |
1995-11-07 |
Astra Ab |
Novel opioid peptides
|
|
US5458887A
(en)
|
1994-03-02 |
1995-10-17 |
Andrx Pharmaceuticals, Inc. |
Controlled release tablet formulation
|
|
DE4413350A1
(de)
|
1994-04-18 |
1995-10-19 |
Basf Ag |
Retard-Matrixpellets und Verfahren zu ihrer Herstellung
|
|
SI9520049A
(en)
|
1994-05-06 |
1997-12-31 |
Pfizer |
Controlled-release dosage forms of azithromycin
|
|
DE19509807A1
(de)
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
|
|
AT403988B
(de)
|
1994-05-18 |
1998-07-27 |
Lannacher Heilmittel |
Festes orales retardpräparat
|
|
US5460826A
(en)
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
|
DE4426245A1
(de)
|
1994-07-23 |
1996-02-22 |
Gruenenthal Gmbh |
1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
|
|
IT1274879B
(it)
|
1994-08-03 |
1997-07-25 |
Saitec Srl |
Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
|
|
JP3285452B2
(ja)
|
1994-08-11 |
2002-05-27 |
サンスター株式会社 |
歯磨組成物
|
|
US5837790A
(en)
|
1994-10-24 |
1998-11-17 |
Amcol International Corporation |
Precipitation polymerization process for producing an oil adsorbent polymer capable of entrapping solid particles and liquids and the product thereof
|
|
AUPM897594A0
(en)
|
1994-10-25 |
1994-11-17 |
Daratech Pty Ltd |
Controlled release container
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
DE4446470A1
(de)
*
|
1994-12-23 |
1996-06-27 |
Basf Ag |
Verfahren zur Herstellung von teilbaren Tabletten
|
|
DE19504832A1
(de)
|
1995-02-14 |
1996-08-22 |
Basf Ag |
Feste Wirkstoff-Zubereitungen
|
|
US5945125A
(en)
|
1995-02-28 |
1999-08-31 |
Temple University |
Controlled release tablet
|
|
US6348469B1
(en)
|
1995-04-14 |
2002-02-19 |
Pharma Pass Llc |
Solid compositions containing glipizide and polyethylene oxide
|
|
US6117453A
(en)
|
1995-04-14 |
2000-09-12 |
Pharma Pass |
Solid compositions containing polyethylene oxide and an active ingredient
|
|
US5900425A
(en)
|
1995-05-02 |
1999-05-04 |
Bayer Aktiengesellschaft |
Pharmaceutical preparations having controlled release of active compound and processes for their preparation
|
|
DE19522899C1
(de)
|
1995-06-23 |
1996-12-19 |
Hexal Pharmaforschung Gmbh |
Verfahren zum kontinuierlichen Ersintern eines Granulats
|
|
US5759583A
(en)
|
1995-08-30 |
1998-06-02 |
Syntex (U.S.A.) Inc. |
Sustained release poly (lactic/glycolic) matrices
|
|
US6007843A
(en)
|
1995-09-29 |
1999-12-28 |
Lam Pharmaceuticals Corp. |
Sustained release delivery system
|
|
US5811126A
(en)
|
1995-10-02 |
1998-09-22 |
Euro-Celtique, S.A. |
Controlled release matrix for pharmaceuticals
|
|
DE19539361A1
(de)
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
|
US6355656B1
(en)
*
|
1995-12-04 |
2002-03-12 |
Celgene Corporation |
Phenidate drug formulations having diminished abuse potential
|
|
US5908850A
(en)
*
|
1995-12-04 |
1999-06-01 |
Celgene Corporation |
Method of treating attention deficit disorders with d-threo methylphenidate
|
|
DE19547766A1
(de)
|
1995-12-20 |
1997-06-26 |
Gruenenthal Gmbh |
1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
|
|
DK0914097T3
(da)
|
1996-03-12 |
2002-04-29 |
Alza Corp |
Sammensætning og doseringsform omfattende opioid antagonist
|
|
US6461644B1
(en)
|
1996-03-25 |
2002-10-08 |
Richard R. Jackson |
Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods
|
|
US20020114838A1
(en)
|
1996-04-05 |
2002-08-22 |
Ayer Atul D. |
Uniform drug delivery therapy
|
|
US6096339A
(en)
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
|
PL189066B1
(pl)
|
1996-04-05 |
2005-06-30 |
Takeda Pharmaceutical |
Kompozycja farmaceutyczna do zapobiegania lub zwalczania chorób związanych z angiotensyną II oraz stosowanie związków do wytwarzania leku do zapobiegania lub zwalczania chorób związanych z angiotensyną II
|
|
US5817343A
(en)
|
1996-05-14 |
1998-10-06 |
Alkermes, Inc. |
Method for fabricating polymer-based controlled-release devices
|
|
IL127378A
(en)
|
1996-06-06 |
2003-07-31 |
Bifodan As |
Enteric coating for an oral preparation
|
|
ATE427124T1
(de)
|
1996-06-26 |
2009-04-15 |
Univ Texas |
Heiss-geschmolzene extrudierbare pharmazeutische formulierung
|
|
WO1998001117A1
(en)
|
1996-07-08 |
1998-01-15 |
Edward Mendell Co., Inc. |
Sustained release matrix for high-dose insoluble drugs
|
|
DE19629753A1
(de)
|
1996-07-23 |
1998-01-29 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
|
NL1003684C2
(nl)
|
1996-07-25 |
1998-01-28 |
Weterings B V H |
Inrichting voor het afgeven van een vloeistof.
|
|
DE19630236A1
(de)
|
1996-07-26 |
1998-01-29 |
Wolff Walsrode Ag |
Biaxial gereckte, biologisch abbaubare und kompostierbare Wursthülle
|
|
BE1010353A5
(fr)
|
1996-08-14 |
1998-06-02 |
Boss Pharmaceuticals Ag |
Procede pour la fabrication de produits pharmaceutiques, dispositif pour un tel procede et produits pharmaceutiques ainsi obtenus.
|
|
DE69731396C5
(de)
|
1996-11-05 |
2013-10-31 |
Novamont S.P.A. |
Biologisch abbaubare Polymerzusammensetzungen, die Stärke und ein thermoplastisches Polymer enthalten
|
|
US5991799A
(en)
|
1996-12-20 |
1999-11-23 |
Liberate Technologies |
Information retrieval system using an internet multiplexer to focus user selection
|
|
DE19705538C1
(de)
|
1997-02-14 |
1998-08-27 |
Goedecke Ag |
Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
DE19710213A1
(de)
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Verfahren zur Herstellung von festen Kombinationsarzneiformen
|
|
DE19710008A1
(de)
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
|
|
DE19710009A1
(de)
|
1997-03-12 |
1998-09-24 |
Knoll Ag |
Mehrphasige wirkstoffhaltige Zubereitungsformen
|
|
US6139770A
(en)
|
1997-05-16 |
2000-10-31 |
Chevron Chemical Company Llc |
Photoinitiators and oxygen scavenging compositions
|
|
DE19721467A1
(de)
|
1997-05-22 |
1998-11-26 |
Basf Ag |
Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
ES2248908T7
(es)
|
1997-06-06 |
2014-11-24 |
Depomed, Inc. |
Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles
|
|
WO1999001111A1
(en)
|
1997-07-02 |
1999-01-14 |
Euro-Celtique, S.A. |
Stabilized sustained release tramadol formulations
|
|
IE970588A1
(en)
|
1997-08-01 |
2000-08-23 |
Elan Corp Plc |
Controlled release pharmaceutical compositions containing tiagabine
|
|
AU741599B2
(en)
|
1997-09-10 |
2001-12-06 |
Fram Group Ip Llc |
Injection molding of structural zirconia-based materials by an aqueous process
|
|
US6009390A
(en)
|
1997-09-11 |
1999-12-28 |
Lucent Technologies Inc. |
Technique for selective use of Gaussian kernels and mixture component weights of tied-mixture hidden Markov models for speech recognition
|
|
US6547997B1
(en)
|
1997-11-28 |
2003-04-15 |
Abbot Laboratories |
Method for producing solvent-free noncrystalline biologically active substances
|
|
KR20010032718A
(ko)
|
1997-12-03 |
2001-04-25 |
빌프리더 하이더 |
폴리에테르 에스테르 아미드
|
|
DE19753534A1
(de)
|
1997-12-03 |
1999-06-10 |
Bayer Ag |
Schnell kristallisierende, biologisch abbaubare Polyesteramide
|
|
US6375957B1
(en)
*
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
IL136805A0
(en)
|
1997-12-22 |
2001-11-25 |
Euro Celtique Sa |
A method of preventing abuse of opioid dosage forms
|
|
DE19800698A1
(de)
|
1998-01-10 |
1999-07-15 |
Bayer Ag |
Biologisch abbaubare Polyesteramide mit blockartig aufgebauten Polyester- und Polyamid-Segmenten
|
|
DE19800689C1
(de)
|
1998-01-10 |
1999-07-15 |
Deloro Stellite Gmbh |
Formkörper aus einem verschleißfesten Werkstoff
|
|
WO1999045067A1
(fr)
|
1998-03-05 |
1999-09-10 |
Mitsui Chemicals, Inc. |
Composition a base d'acide polylactique et son film
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US6090411A
(en)
|
1998-03-09 |
2000-07-18 |
Temple University |
Monolithic tablet for controlled drug release
|
|
US6110500A
(en)
|
1998-03-25 |
2000-08-29 |
Temple University |
Coated tablet with long term parabolic and zero-order release kinetics
|
|
KR20010042419A
(ko)
|
1998-04-02 |
2001-05-25 |
조셉 제이. 스위니 |
낮은 ｋ 유전체를 에칭하는 방법
|
|
CA2327685C
(en)
|
1998-04-03 |
2008-11-18 |
Bm Research A/S |
Controlled release composition
|
|
US5962488A
(en)
|
1998-04-08 |
1999-10-05 |
Roberts Laboratories, Inc. |
Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
|
|
DE19822979A1
(de)
|
1998-05-25 |
1999-12-02 |
Kalle Nalo Gmbh & Co Kg |
Folie mit Stärke oder Stärkederivaten und Polyesterurethanen sowie Verfahren zu ihrer Herstellung
|
|
US6333087B1
(en)
|
1998-08-27 |
2001-12-25 |
Chevron Chemical Company Llc |
Oxygen scavenging packaging
|
|
DE19841244A1
(de)
|
1998-09-09 |
2000-03-16 |
Knoll Ag |
Verfahren und Vorrichtung zum Herstellen von Tabletten
|
|
US6268177B1
(en)
|
1998-09-22 |
2001-07-31 |
Smithkline Beecham Corporation |
Isolated nucleic acid encoding nucleotide pyrophosphorylase
|
|
CN1327384A
(zh)
|
1998-10-20 |
2001-12-19 |
韩国科学技术研究院 |
作为血浆高密度脂蛋白浓度增高剂的生物类黄酮
|
|
US6322819B1
(en)
|
1998-10-21 |
2001-11-27 |
Shire Laboratories, Inc. |
Oral pulsed dose drug delivery system
|
|
US20060240105A1
(en)
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
|
ES2141688B1
(es)
|
1998-11-06 |
2001-02-01 |
Vita Invest Sa |
Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
|
|
DE19855440A1
(de)
|
1998-12-01 |
2000-06-08 |
Basf Ag |
Verfahren zum Herstellen fester Darreichungsformen mittels Schmelzextrusion
|
|
DE19856147A1
(de)
|
1998-12-04 |
2000-06-08 |
Knoll Ag |
Teilbare feste Dosierungsformen und Verfahren zu ihrer Herstellung
|
|
EP1005863A1
(en)
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
US6238697B1
(en)
|
1998-12-21 |
2001-05-29 |
Pharmalogix, Inc. |
Methods and formulations for making bupropion hydrochloride tablets using direct compression
|
|
AU3469100A
(en)
|
1999-01-05 |
2000-07-24 |
Copley Pharmaceutical Inc. |
Sustained release formulation with reduced moisture sensitivity
|
|
AU2255800A
(en)
|
1999-02-04 |
2000-08-25 |
Nichimo Co. Ltd. |
Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6375963B1
(en)
|
1999-06-16 |
2002-04-23 |
Michael A. Repka |
Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
|
|
US20030118641A1
(en)
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
|
EP1204406A2
(en)
|
1999-07-29 |
2002-05-15 |
Roxane Laboratories, Inc. |
Opioid sustained-released formulation
|
|
US6562375B1
(en)
|
1999-08-04 |
2003-05-13 |
Yamanouchi Pharmaceuticals, Co., Ltd. |
Stable pharmaceutical composition for oral use
|
|
EP1205190B1
(en)
|
1999-08-04 |
2006-05-03 |
Astellas Pharma Inc. |
Stable medicinal compositions for oral use using ferric oxides
|
|
KR100345214B1
(ko)
|
1999-08-17 |
2002-07-25 |
이강춘 |
생체적합성 고분자가 수식된 펩타이드의 비점막 전달
|
|
DE19940944B4
(de)
|
1999-08-31 |
2006-10-12 |
Grünenthal GmbH |
Retardierte, orale, pharmazeutische Darreichungsformen
|
|
ES2226886T3
(es)
|
1999-08-31 |
2005-04-01 |
Grunenthal Gmbh |
Forma de administracion de accion retardada que contiene sacarinato de tramadol.
|
|
DE19940740A1
(de)
|
1999-08-31 |
2001-03-01 |
Gruenenthal Gmbh |
Pharmazeutische Salze
|
|
DE19960494A1
(de)
|
1999-12-15 |
2001-06-21 |
Knoll Ag |
Vorrichtung und Verfahren zum Herstellen von festen wirkstoffhaltigen Formen
|
|
ES2160534B1
(es)
|
1999-12-30 |
2002-04-16 |
Vita Invest Sa |
Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
|
|
US6680070B1
(en)
|
2000-01-18 |
2004-01-20 |
Albemarle Corporation |
Particulate blends and compacted products formed therefrom, and the preparation thereof
|
|
AP1665A
(en)
|
2000-02-08 |
2006-09-22 |
Euro Celtique Sa |
Tamper-resistant oral opioid agonist formulations.
|
|
US20020015730A1
(en)
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
DE10015479A1
(de)
|
2000-03-29 |
2001-10-11 |
Basf Ag |
Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
|
|
US8012504B2
(en)
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
|
US6572887B2
(en)
|
2000-05-01 |
2003-06-03 |
National Starch And Chemical Investment Holding Corporation |
Polysaccharide material for direct compression
|
|
US6419954B1
(en)
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
|
EP1289553B1
(en)
*
|
2000-05-23 |
2011-07-13 |
CeNeS Pharmaceuticals, Inc. |
Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
|
|
DE10029201A1
(de)
|
2000-06-19 |
2001-12-20 |
Basf Ag |
Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
|
|
US6488962B1
(en)
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
|
US6607748B1
(en)
|
2000-06-29 |
2003-08-19 |
Vincent Lenaerts |
Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
|
|
DE10036400A1
(de)
|
2000-07-26 |
2002-06-06 |
Mitsubishi Polyester Film Gmbh |
Weiße, biaxial orientierte Polyesterfolie
|
|
AU2001292993A1
(en)
|
2000-09-25 |
2002-04-08 |
Pro-Pharmaceuticals, Inc. |
Compositions for reducing side effects in chemotherapeutic treatments
|
|
AU2001290133A1
(en)
|
2000-09-27 |
2002-04-08 |
Danisco A/S |
Antimicrobial agent
|
|
AU2001294902A1
(en)
|
2000-09-28 |
2002-04-08 |
The Dow Chemical Company |
Polymer composite structures useful for controlled release systems
|
|
GB0026137D0
(en)
|
2000-10-25 |
2000-12-13 |
Euro Celtique Sa |
Transdermal dosage form
|
|
US6344215B1
(en)
|
2000-10-27 |
2002-02-05 |
Eurand America, Inc. |
Methylphenidate modified release formulations
|
|
KR100968128B1
(ko)
*
|
2000-10-30 |
2010-07-06 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
|
AU2002226098A1
(en)
|
2000-10-30 |
2002-05-15 |
The Board Of Regents, The University Of Texas System |
Spherical particles produced by a hot-melt extrusion/spheronization process
|
|
DE10109763A1
(de)
|
2001-02-28 |
2002-09-05 |
Gruenenthal Gmbh |
Pharmazeutische Salze
|
|
JP2002265592A
(ja)
|
2001-03-07 |
2002-09-18 |
Sumitomo Seika Chem Co Ltd |
アルキレンオキシド重合体の製造方法
|
|
WO2002071860A1
(en)
|
2001-03-13 |
2002-09-19 |
L.A. Dreyfus Co. |
Gum base and gum manufacturing using particulated gum base ingredients
|
|
JP3967554B2
(ja)
|
2001-03-15 |
2007-08-29 |
株式会社ポッカコーポレーション |
フラボノイド化合物及びその製造方法
|
|
EP1241110A1
(en)
|
2001-03-16 |
2002-09-18 |
Pfizer Products Inc. |
Dispensing unit for oxygen-sensitive drugs
|
|
US20020132395A1
(en)
|
2001-03-16 |
2002-09-19 |
International Business Machines Corporation |
Body contact in SOI devices by electrically weakening the oxide under the body
|
|
US20020187192A1
(en)
|
2001-04-30 |
2002-12-12 |
Yatindra Joshi |
Pharmaceutical composition which reduces or eliminates drug abuse potential
|
|
DE60211885T2
(de)
|
2001-05-01 |
2006-11-02 |
Union Carbide Chemicals & Plastics Technology Corp., Danbury |
Pharmazeutische zusammensetzung enthaltend polyalkylenoxide mit verringerten mengen an ameisensäure und ameisensäurederivaten
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
|
US6623754B2
(en)
|
2001-05-21 |
2003-09-23 |
Noveon Ip Holdings Corp. |
Dosage form of N-acetyl cysteine
|
|
US7125561B2
(en)
|
2001-05-22 |
2006-10-24 |
Euro-Celtique S.A. |
Compartmentalized dosage form
|
|
US20030064122A1
(en)
|
2001-05-23 |
2003-04-03 |
Endo Pharmaceuticals, Inc. |
Abuse resistant pharmaceutical composition containing capsaicin
|
|
WO2003002100A1
(en)
|
2001-06-26 |
2003-01-09 |
Farrell John J |
Tamper-proof narcotic delivery system
|
|
US20030008409A1
(en)
|
2001-07-03 |
2003-01-09 |
Spearman Steven R. |
Method and apparatus for determining sunlight exposure
|
|
WO2003004032A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Endo Pharmaceuticals, Inc. |
Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
|
|
US8329216B2
(en)
*
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
|
ES2292775T3
(es)
|
2001-07-06 |
2008-03-16 |
Penwest Pharmaceuticals Co. |
Formulaciones de liberacion prolongada de oximorfona.
|
|
JP2003020517A
(ja)
|
2001-07-10 |
2003-01-24 |
Calp Corp |
複合繊維用樹脂組成物
|
|
JP4256259B2
(ja)
*
|
2001-07-18 |
2009-04-22 |
ユーロ−セルティーク エス．エイ． |
オキシコドン及びナロキソンの医薬配合物
|
|
US6883976B2
(en)
|
2001-07-30 |
2005-04-26 |
Seikoh Giken Co., Ltd. |
Optical fiber ferrule assembly and optical module and optical connector using the same
|
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
|
US7141250B2
(en)
*
|
2001-08-06 |
2006-11-28 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing bittering agent
|
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
|
US7157103B2
(en)
|
2001-08-06 |
2007-01-02 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing irritant
|
|
IL160217A0
(en)
|
2001-08-06 |
2004-07-25 |
Euro Celtique Sa |
Compositions and methods to prevent abuse of opioids
|
|
WO2003015531A2
(en)
|
2001-08-06 |
2003-02-27 |
Thomas Gruber |
Pharmaceutical formulation containing dye
|
|
US20030068375A1
(en)
*
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
HUP0401195A3
(en)
|
2001-08-06 |
2006-11-28 |
Euro Celtique Sa |
Compositions to prevent abuse of opioids containing aversive agent and process of their preparation
|
|
AU2002324624A1
(en)
|
2001-08-06 |
2003-02-24 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
|
US7144587B2
(en)
|
2001-08-06 |
2006-12-05 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
|
|
JP3474870B2
(ja)
|
2001-08-08 |
2003-12-08 |
菱計装株式会社 |
昇降機
|
|
US20030049272A1
(en)
|
2001-08-30 |
2003-03-13 |
Yatindra Joshi |
Pharmaceutical composition which produces irritation
|
|
US20030059467A1
(en)
|
2001-09-14 |
2003-03-27 |
Pawan Seth |
Pharmaceutical composition comprising doxasozin
|
|
US6691698B2
(en)
|
2001-09-14 |
2004-02-17 |
Fmc Technologies Inc. |
Cooking oven having curved heat exchanger
|
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
|
US20030092724A1
(en)
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
|
US20050019399A1
(en)
|
2001-09-21 |
2005-01-27 |
Gina Fischer |
Controlled release solid dispersions
|
|
WO2003024430A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Morphine polymer release system
|
|
AU2002342755A1
(en)
|
2001-09-26 |
2003-04-14 |
Klaus-Jurgen Steffens |
Method and device for producing granulates that comprise at least one pharmaceutical active substance
|
|
WO2003026743A2
(en)
|
2001-09-26 |
2003-04-03 |
Penwest Pharmaceuticals Company |
Opioid formulations having reduced potential for abuse
|
|
US6837696B2
(en)
|
2001-09-28 |
2005-01-04 |
Mcneil-Ppc, Inc. |
Apparatus for manufacturing dosage forms
|
|
CN1592611A
(zh)
|
2001-09-28 |
2005-03-09 |
麦克内尔-Ppc股份有限公司 |
改良释放的剂型
|
|
ES2261741T3
(es)
|
2001-10-09 |
2006-11-16 |
THE PROCTER & GAMBLE COMPANY |
Composiciones acuosas para tratar una superficie.
|
|
US6592901B2
(en)
|
2001-10-15 |
2003-07-15 |
Hercules Incorporated |
Highly compressible ethylcellulose for tableting
|
|
JP2003125706A
(ja)
|
2001-10-23 |
2003-05-07 |
Lion Corp |
口中清涼製剤
|
|
PE20030527A1
(es)
|
2001-10-24 |
2003-07-26 |
Gruenenthal Chemie |
Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
|
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
US20030104052A1
(en)
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030152622A1
(en)
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US6723340B2
(en)
*
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
|
CA2464653C
(en)
*
|
2001-10-29 |
2011-10-18 |
Therics, Inc. |
System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
|
|
US20040126428A1
(en)
*
|
2001-11-02 |
2004-07-01 |
Lyn Hughes |
Pharmaceutical formulation including a resinate and an aversive agent
|
|
CA2464528A1
(en)
|
2001-11-02 |
2003-05-15 |
Elan Corporation, Plc |
Pharmaceutical composition
|
|
EP1463515A4
(en)
|
2001-12-06 |
2005-01-12 |
Scolr Pharma Inc |
ISOFLAVONAL COMPOSITION FOR ORAL ADMINISTRATION
|
|
FR2833838B1
(fr)
|
2001-12-21 |
2005-09-16 |
Ellipse Pharmaceuticals |
Procede de fabrication d'un comprime incluant un analgesique de type morphinique et comprime obtenu
|
|
AUPS044502A0
(en)
|
2002-02-11 |
2002-03-07 |
Commonwealth Scientific And Industrial Research Organisation |
Novel catalysts and processes for their preparation
|
|
US20040033253A1
(en)
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
|
US20030190343A1
(en)
|
2002-03-05 |
2003-10-09 |
Pfizer Inc. |
Palatable pharmaceutical compositions for companion animals
|
|
US6572889B1
(en)
|
2002-03-07 |
2003-06-03 |
Noveon Ip Holdings Corp. |
Controlled release solid dosage carbamazepine formulations
|
|
US6753009B2
(en)
|
2002-03-13 |
2004-06-22 |
Mcneil-Ppc, Inc. |
Soft tablet containing high molecular weight polyethylene oxide
|
|
CN100411611C
(zh)
|
2002-04-05 |
2008-08-20 |
欧洲凯尔蒂克公司 |
用于持续,不变且独立释放活性化合物的基质
|
|
DE10217232B4
(de)
|
2002-04-18 |
2004-08-19 |
Ticona Gmbh |
Verfahren zur Herstellung gefüllter Granulate aus Polyethylenen hohen bzw. ultrahohen Molekulargewichts
|
|
US6960617B2
(en)
|
2002-04-22 |
2005-11-01 |
Purdue Research Foundation |
Hydrogels having enhanced elasticity and mechanical strength properties
|
|
US20050106249A1
(en)
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
|
BR0309620A
(pt)
|
2002-04-29 |
2005-03-15 |
Alza Corp |
Métodos e formas de dosagem para liberação controlada de oxicodona
|
|
CA2486075A1
(en)
|
2002-05-13 |
2003-11-20 |
Endo Pharmaceuticals Inc. |
Abuse-resistant opioid solid dosage form
|
|
DE10250083A1
(de)
|
2002-06-17 |
2003-12-24 |
Gruenenthal Gmbh |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
JP4694207B2
(ja)
|
2002-07-05 |
2011-06-08 |
コルジウム ファーマシューティカル， インコーポレイテッド |
オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
|
|
US20040011806A1
(en)
|
2002-07-17 |
2004-01-22 |
Luciano Packaging Technologies, Inc. |
Tablet filler device with star wheel
|
|
US20070196481A1
(en)
|
2002-07-25 |
2007-08-23 |
Amidon Gregory E |
Sustained-release tablet composition
|
|
US7388068B2
(en)
|
2002-08-21 |
2008-06-17 |
Clariant Produkte (Deutschland) Gmbh |
Copolymers made of alkylene oxides and glycidyl ethers and use thereof as polymerizable emulsifiers
|
|
JP2006501234A
(ja)
|
2002-08-21 |
2006-01-12 |
フォークス ファーマシューティカルズ リミテッド |
錠剤製造における、クエン酸およびラクチトール等の水溶性糖水溶液の、造粒液としての使用
|
|
US20040052844A1
(en)
|
2002-09-16 |
2004-03-18 |
Fang-Hsiung Hsiao |
Time-controlled, sustained release, pharmaceutical composition containing water-soluble resins
|
|
PT1635830E
(pt)
|
2002-09-17 |
2008-12-31 |
Wyeth Corp |
Formulação granulada do éster de rapamicina cci-779
|
|
EP1539098B1
(en)
|
2002-09-20 |
2011-08-10 |
Fmc Corporation |
Cosmetic composition containing microcrystalline cellulose
|
|
EP1555022B1
(en)
|
2002-09-21 |
2008-02-20 |
Shuyi Zhang |
Sustained release formulation of acetaminophen and tramadol
|
|
WO2004026262A2
(en)
|
2002-09-23 |
2004-04-01 |
Verion, Inc. |
Abuse-resistant pharmaceutical compositions
|
|
AR045972A1
(es)
|
2002-10-25 |
2005-11-23 |
Labopharm Inc |
Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas
|
|
DE10250087A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE10250088A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE10250084A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US20050191244A1
(en)
*
|
2002-10-25 |
2005-09-01 |
Gruenenthal Gmbh |
Abuse-resistant pharmaceutical dosage form
|
|
US20050186139A1
(en)
|
2002-10-25 |
2005-08-25 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
DE10252667A1
(de)
|
2002-11-11 |
2004-05-27 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
US20040091528A1
(en)
|
2002-11-12 |
2004-05-13 |
Yamanouchi Pharma Technologies, Inc. |
Soluble drug extended release system
|
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
US7442387B2
(en)
|
2003-03-06 |
2008-10-28 |
Astellas Pharma Inc. |
Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
|
|
ATE454169T1
(de)
|
2003-03-13 |
2010-01-15 |
Controlled Chemicals Inc |
Oxycodon- konjugate mit niedrigerem missbrauch- potential und ausgedehnter tätigkeitsdauer
|
|
DE602004025159D1
(de)
|
2003-03-26 |
2010-03-04 |
Egalet As |
Matrixzubereitungen für die kontrollierte Darreichung von Arzneistoffen
|
|
DE602004031096D1
(de)
|
2003-03-26 |
2011-03-03 |
Egalet As |
Morphin-system mit kontrollierter freisetzung
|
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
|
US9579286B2
(en)
|
2003-04-21 |
2017-02-28 |
Purdue Pharma L.P. |
Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same
|
|
UA82880C2
(en)
|
2003-04-30 |
2008-05-26 |
|
Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
|
|
US8906413B2
(en)
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
|
CN1473562A
(zh)
|
2003-06-27 |
2004-02-11 |
辉 刘 |
儿用口腔速溶、速崩冻干片及其制备方法
|
|
US20050015730A1
(en)
|
2003-07-14 |
2005-01-20 |
Srimanth Gunturi |
Systems, methods and computer program products for identifying tab order sequence of graphically represented elements
|
|
EP1842533B1
(de)
|
2003-08-06 |
2013-05-01 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE102004032051A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
CL2004002016A1
(es)
|
2003-08-06 |
2005-05-20 |
Gruenenthal Chemie |
Forma de dosificacion termoformada a prueba de abuso que contiene (a) uno o mas principios activos susceptibles de abuso, (b) opcionalmente sustancias auxiliares, (c) al menos un polimero sintetico o natural definido y (d) opcionalmente al menos una
|
|
RU2339365C2
(ru)
|
2003-08-06 |
2008-11-27 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE102004020220A1
(de)
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
US20050063214A1
(en)
|
2003-09-22 |
2005-03-24 |
Daisaburo Takashima |
Semiconductor integrated circuit device
|
|
ATE464049T1
(de)
|
2003-09-25 |
2010-04-15 |
Euro Celtique Sa |
Pharmazeutische kombinationen von hydrocodon und naltrexon
|
|
BRPI0414941A
(pt)
|
2003-09-30 |
2006-11-07 |
Alza Corp |
dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente
|
|
US20060172006A1
(en)
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
|
US20060009478A1
(en)
|
2003-10-15 |
2006-01-12 |
Nadav Friedmann |
Methods for the treatment of back pain
|
|
CN1933837A
(zh)
|
2003-10-29 |
2007-03-21 |
阿尔扎公司 |
一天一次经口受控释放氧可酮剂型
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
ES2600577T3
(es)
|
2003-12-04 |
2017-02-09 |
Bend Research, Inc. |
Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
|
|
DE602004005076T2
(de)
|
2003-12-09 |
2007-11-15 |
Euro-Celtique S.A. |
Co-extrudierte sicherheits-dosierform mit einem wirkstoff und einem adversen mittel und herstellungsverfahren dafür
|
|
WO2005060942A1
(en)
|
2003-12-19 |
2005-07-07 |
Aurobindo Pharma Ltd |
Extended release pharmaceutical composition of metformin
|
|
DE10360792A1
(de)
|
2003-12-23 |
2005-07-28 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
GB0716126D0
(en)
|
2007-08-17 |
2007-09-26 |
Danisco |
Process
|
|
JP2007517061A
(ja)
|
2003-12-29 |
2007-06-28 |
アルザ・コーポレーシヨン |
新規薬剤組成物及び投与形態物
|
|
US20070196396A1
(en)
|
2004-02-11 |
2007-08-23 |
Rubicon Research Private Limited |
Controlled release pharmaceutical compositions with improved bioavailability
|
|
TWI350762B
(en)
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
|
GB0403098D0
(en)
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Extrusion
|
|
GB0403100D0
(en)
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Particulates
|
|
EP1718258B1
(en)
|
2004-02-23 |
2009-03-25 |
Euro-Celtique S.A. |
Abuse resistance opioid transdermal delivery device
|
|
TWI483944B
(zh)
*
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
|
US20050220877A1
(en)
|
2004-03-31 |
2005-10-06 |
Patel Ashish A |
Bilayer tablet comprising an antihistamine and a decongestant
|
|
DE102004019916A1
(de)
|
2004-04-21 |
2005-11-17 |
Grünenthal GmbH |
Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
|
|
WO2005102286A1
(de)
|
2004-04-22 |
2005-11-03 |
Grünenthal GmbH |
Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform
|
|
WO2005105036A1
(en)
|
2004-04-28 |
2005-11-10 |
Natco Pharma Limited |
Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation
|
|
TWI356036B
(en)
|
2004-06-09 |
2012-01-11 |
Smithkline Beecham Corp |
Apparatus and method for pharmaceutical production
|
|
PL1612203T3
(pl)
|
2004-06-28 |
2007-12-31 |
Gruenenthal Gmbh |
Krystaliczne postacie chlorowodorku (-)-(1R,2R)-3-(3-dimetyloamino-1-etylo-2-metylo-propylo)fenolu
|
|
ITMI20041317A1
(it)
|
2004-06-30 |
2004-09-30 |
Ibsa Inst Biochimique Sa |
Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
|
|
AR053304A1
(es)
|
2004-07-01 |
2007-05-02 |
Gruenenthal Gmbh |
Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion.
|
|
DE102004032103A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
FI1765303T4
(fi)
|
2004-07-01 |
2023-01-31 |
|
Väärinkäytöltä suojattu oraalinen tabletti
|
|
PL1765298T3
(pl)
|
2004-07-01 |
2013-01-31 |
Gruenenthal Gmbh |
Sposób wytwarzania stałej postaci dawkowania, która jest zabezpieczona przez nadużywaniem, wykorzystujący wytłaczarkę z przekładnią planetarną
|
|
ATE396703T1
(de)
|
2004-07-27 |
2008-06-15 |
Unilever Nv |
Haarpflegezusammensetzungen
|
|
US20070077297A1
(en)
|
2004-09-30 |
2007-04-05 |
Scolr Pharma, Inc. |
Modified release ibuprofen dosage form
|
|
US20060068009A1
(en)
|
2004-09-30 |
2006-03-30 |
Scolr Pharma, Inc. |
Modified release ibuprofen dosage form
|
|
US20080152595A1
(en)
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20070231268A1
(en)
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20060177380A1
(en)
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
DK1849470T4
(en)
|
2005-01-26 |
2024-04-02 |
Taiho Pharmaceutical Co Ltd |
Cancerlægemiddel, som indeholder alpha, alpha, alpha-trifluorthymidin og thymidin-phosphorylase-inhibitor
|
|
BRPI0606339A2
(pt)
|
2005-01-28 |
2009-06-16 |
Euro Celtique Sa |
formas farmacêuticas resistentes a álcool
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
US7292616B2
(en)
|
2005-02-09 |
2007-11-06 |
Ultratech, Inc. |
CO2 laser stabilization systems and methods
|
|
EP1853249A2
(en)
|
2005-02-10 |
2007-11-14 |
LifeCycle Pharma A/S |
A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor
|
|
US20060194759A1
(en)
|
2005-02-25 |
2006-08-31 |
Eidelson Stewart G |
Topical compositions and methods for treating pain and inflammation
|
|
EP1695700A1
(en)
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
|
CA2598774C
(en)
*
|
2005-03-04 |
2010-12-21 |
Euro-Celtique S.A. |
Method of reducing alpha, beta unsaturated ketones in opioid compositions
|
|
US7732427B2
(en)
|
2005-03-31 |
2010-06-08 |
University Of Delaware |
Multifunctional and biologically active matrices from multicomponent polymeric solutions
|
|
RU2406480C2
(ru)
|
2005-04-08 |
2010-12-20 |
Озфарма Пти Лтд |
Трансбуккальная система доставки
|
|
EP1881819A1
(en)
|
2005-05-10 |
2008-01-30 |
Novartis AG |
Extrusion process for making compositions with poorly compressible therapeutic compounds
|
|
JP5161075B2
(ja)
|
2005-06-03 |
2013-03-13 |
エガレット エイ／エス |
分散媒体の第１フラクションとマトリックスの第２フラクションを有し、第２フラクションが胃腸の液体に少なくとも部分的に最初に曝される固形の医薬組成物
|
|
WO2007005716A2
(en)
|
2005-06-30 |
2007-01-11 |
Cinergen, Llc |
Methods of treatment and compositions for use thereof
|
|
KR20080039400A
(ko)
|
2005-07-07 |
2008-05-07 |
파남 컴퍼니스 인크. |
고수용성 약물의 서방성 약학 조성물
|
|
US8858993B2
(en)
|
2005-07-25 |
2014-10-14 |
Metrics, Inc. |
Coated tablet with zero-order or near zero-order release kinetics
|
|
JP2009503071A
(ja)
|
2005-08-03 |
2009-01-29 |
イーストマン ケミカル カンパニー |
トコフェリルポリエチレングリコールスクシネート粉末及びその製造方法
|
|
JP5118973B2
(ja)
|
2005-10-14 |
2013-01-16 |
学校法人北里研究所 |
新規ジヒドロシュードエリスロマイシン誘導体
|
|
US20070092573A1
(en)
|
2005-10-24 |
2007-04-26 |
Laxminarayan Joshi |
Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist
|
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
US8329744B2
(en)
|
2005-11-02 |
2012-12-11 |
Relmada Therapeutics, Inc. |
Methods of preventing the serotonin syndrome and compositions for use thereof
|
|
WO2008134071A1
(en)
*
|
2007-04-26 |
2008-11-06 |
Theraquest Biosciences, Inc. |
Multimodal abuse resistant extended release formulations
|
|
US8652529B2
(en)
*
|
2005-11-10 |
2014-02-18 |
Flamel Technologies |
Anti-misuse microparticulate oral pharmaceutical form
|
|
FR2892937B1
(fr)
|
2005-11-10 |
2013-04-05 |
Flamel Tech Sa |
Forme pharmaceutique orale microparticulaire anti-mesusage
|
|
US20090317355A1
(en)
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20100172989A1
(en)
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090022798A1
(en)
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
CA2637755A1
(en)
|
2006-01-21 |
2007-07-26 |
Abbott Gmbh & Co. Kg |
Dosage form and method for the delivery of drugs of abuse
|
|
EP1813276A1
(en)
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
|
FR2898056B1
(fr)
|
2006-03-01 |
2012-01-20 |
Ethypharm Sa |
Comprimes resistant a l'ecrasement destines a eviter le detournement illicite
|
|
US20100226855A1
(en)
*
|
2006-03-02 |
2010-09-09 |
Spherics, Inc. |
Rate-Controlled Oral Dosage Formulations
|
|
US8871779B2
(en)
|
2006-03-02 |
2014-10-28 |
Mallinckrodt Llc |
Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds
|
|
CA2932389A1
(en)
|
2006-03-24 |
2007-10-04 |
Auxilium International Holdings, Inc. |
Stabilized compositions containing alkaline labile drugs
|
|
WO2007112285A2
(en)
|
2006-03-24 |
2007-10-04 |
Auxilium Pharmaceuticals, Inc. |
Process for the preparation of a hot-melt extruded laminate
|
|
US20070224637A1
(en)
|
2006-03-24 |
2007-09-27 |
Mcauliffe Joseph C |
Oxidative protection of lipid layer biosensors
|
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
|
US9023400B2
(en)
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|
|
US20070292508A1
(en)
|
2006-06-05 |
2007-12-20 |
Balchem Corporation |
Orally disintegrating dosage forms
|
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
|
CN101091721A
(zh)
|
2006-06-22 |
2007-12-26 |
孙明 |
阿胶新剂型的制备方法
|
|
JP4029109B1
(ja)
|
2006-07-18 |
2008-01-09 |
タマ生化学株式会社 |
ビタミンｅとプロリンの複合体粉末及びその製造方法
|
|
CA2671197A1
(en)
|
2006-07-21 |
2008-01-24 |
Lab International Srl |
Hydrophobic abuse deterrent delivery system
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
US8445018B2
(en)
*
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
|
US8187636B2
(en)
|
2006-09-25 |
2012-05-29 |
Atlantic Pharmaceuticals, Inc. |
Dosage forms for tamper prone therapeutic agents
|
|
KR101400824B1
(ko)
|
2006-09-25 |
2014-05-29 |
후지필름 가부시키가이샤 |
레지스트 조성물, 이 레지스트 조성물에 사용되는 수지, 이수지의 합성에 사용되는 화합물, 및 상기 레지스트조성물을 사용한 패턴형성방법
|
|
US20080085304A1
(en)
|
2006-10-10 |
2008-04-10 |
Penwest Pharmaceuticals Co. |
Robust sustained release formulations
|
|
GB0624880D0
(en)
*
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
|
DE102006062120A1
(de)
|
2006-12-22 |
2008-06-26 |
Grünenthal GmbH |
Pharmazeutische Zusammensetzung zur Aknebehandlung
|
|
EP2104493A2
(en)
|
2007-01-16 |
2009-09-30 |
Egalet A/S |
Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
WO2008094877A2
(en)
|
2007-01-30 |
2008-08-07 |
Drugtech Corporation |
Compositions for oral delivery of pharmaceuticals
|
|
CN100579525C
(zh)
|
2007-02-02 |
2010-01-13 |
东南大学 |
盐酸尼卡地平缓释制剂及其制备方法
|
|
CN101057849A
(zh)
|
2007-02-27 |
2007-10-24 |
齐齐哈尔医学院 |
含有盐酸二甲双胍和格列吡嗪的缓释制剂及其制备方法
|
|
EP2144599B1
(en)
|
2007-03-02 |
2010-08-04 |
Farnam Companies, Inc. |
Sustained release pellets comprising wax-like material
|
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
EP1980245A1
(en)
|
2007-04-11 |
2008-10-15 |
Cephalon France |
Bilayer lyophilized pharmaceutical compositions and methods of making and using same
|
|
EP2061587A1
(en)
|
2007-04-26 |
2009-05-27 |
Sigmoid Pharma Limited |
Manufacture of multiple minicapsules
|
|
WO2008142627A2
(en)
|
2007-05-17 |
2008-11-27 |
Ranbaxy Laboratories Limited |
Multilayered modified release formulation comprising amoxicillin and clavulanate
|
|
US8202542B1
(en)
|
2007-05-31 |
2012-06-19 |
Tris Pharma |
Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings
|
|
CA2687192C
(en)
|
2007-06-04 |
2015-11-24 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
US20100035886A1
(en)
|
2007-06-21 |
2010-02-11 |
Veroscience, Llc |
Parenteral formulations of dopamine agonists
|
|
DE102007030308A1
(de)
|
2007-06-29 |
2009-01-02 |
Printed Systems Gmbh |
Verfahren zum Herstellen einer Speicherstruktur
|
|
CA2690956C
(en)
|
2007-07-01 |
2017-01-03 |
Joseph Peter Habboushe |
Combination tablet with chewable outer layer
|
|
NZ581767A
(en)
|
2007-07-20 |
2012-05-25 |
Abbott Gmbh & Co Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
EP2200591A2
(en)
|
2007-09-11 |
2010-06-30 |
Ranbaxy Laboratories Limited |
Controlled release pharmaceutical dosage forms of trimetazidine
|
|
WO2009035474A1
(en)
|
2007-09-13 |
2009-03-19 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
|
EP2211760A4
(en)
|
2007-10-17 |
2013-09-18 |
Axxia Pharmaceuticals Llc |
POLYMER DRUG DELIVERY SYSTEMS AND METHODS OF EXTRUSION OF THERMOPLASTIC COMPOUNDS TO PRODUCE THESE SYSTEMS
|
|
CN102908339A
(zh)
|
2007-11-23 |
2013-02-06 |
格吕伦塔尔有限公司 |
他喷他多组合物
|
|
JP2011506319A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
|
|
AU2008334580A1
(en)
|
2007-12-12 |
2009-06-18 |
Basf Se |
Salts of active ingredients with polymeric counter-ions
|
|
US8486448B2
(en)
|
2007-12-17 |
2013-07-16 |
Paladin Labs Inc. |
Misuse preventative, controlled release formulation
|
|
NZ586792A
(en)
|
2008-01-25 |
2012-09-28 |
Gruenenthal Chemie |
Tamper resistant controlled release pharmaceutical tablets form having convex and concave surfaces
|
|
KR100970665B1
(ko)
|
2008-02-04 |
2010-07-15 |
삼일제약주식회사 |
알푸조신 또는 그의 염을 함유하는 서방성 정제
|
|
AU2009220779A1
(en)
|
2008-03-05 |
2009-09-11 |
Panacea Biotec Limited |
Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
|
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
|
EP2100598A1
(en)
*
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
ES2599031T3
(es)
|
2008-05-09 |
2017-01-31 |
Grünenthal GmbH |
Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización
|
|
WO2010003078A2
(en)
|
2008-07-03 |
2010-01-07 |
Novartis Ag |
Melt granulation process
|
|
RU2483713C2
(ru)
|
2008-08-20 |
2013-06-10 |
Борд Оф Риджентс, Зе Юниверсити Оф Техас Систем |
Экструзия горячего расплава множественных частиц модифицированного высвобождения
|
|
WO2010044842A1
(en)
|
2008-10-16 |
2010-04-22 |
University Of Tennessee Research Foundation |
Tamper resistant oral dosage forms containing an embolizing agent
|
|
PE20110855A1
(es)
|
2008-10-27 |
2011-12-05 |
Alza Corp |
Forma de dosificacion oral de liberacion prolongada de acetaminofeno/tramadol
|
|
US20100151019A1
(en)
|
2008-11-14 |
2010-06-17 |
Portola Pharmaceuticals, Inc. |
SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS WITH POOR AQUEOUS SOLUBILITY AT LOW pH AND METHODS OF USE THEREOF
|
|
EP2379111B1
(en)
|
2008-12-12 |
2013-03-20 |
Paladin Labs Inc. |
Narcotic drug formulations with decreased abuse potential
|
|
CN102316857A
(zh)
|
2008-12-16 |
2012-01-11 |
莱博法姆公司 |
防止误用的控释配方
|
|
NZ594071A
(en)
*
|
2009-01-26 |
2013-01-25 |
Egalet Ltd |
Controlled release formulations comprising morphine sulphate for continuous treatment of pain
|
|
AU2010211376B2
(en)
|
2009-02-06 |
2013-08-22 |
Egalet Ltd. |
Pharmaceutical compositions resistant to abuse
|
|
KR101571198B1
(ko)
|
2009-03-18 |
2015-11-23 |
에보니크 룀 게엠베하 |
중성 비닐 중합체 및 부형제를 포함하는 코팅을 이용하는, 에탄올의 영향에 대한 내성을 갖는 제어 방출 제약 조성물
|
|
EP2246063A1
(en)
|
2009-04-29 |
2010-11-03 |
Ipsen Pharma S.A.S. |
Sustained release formulations comprising GnRH analogues
|
|
GB0909680D0
(en)
|
2009-06-05 |
2009-07-22 |
Euro Celtique Sa |
Dosage form
|
|
AU2010265213B2
(en)
*
|
2009-06-24 |
2012-08-23 |
Egalet Ltd. |
Controlled release formulations
|
|
WO2011008298A2
(en)
|
2009-07-16 |
2011-01-20 |
Nectid, Inc. |
Novel axomadol dosage forms
|
|
AU2010275753B2
(en)
|
2009-07-22 |
2014-08-21 |
Grünenthal GmbH |
Hot-melt extruded controlled release dosage form
|
|
US20110020451A1
(en)
|
2009-07-22 |
2011-01-27 |
Grunenthal Gmbh |
Tamper-resistant dosage form for oxidation-sensitive opioids
|
|
WO2011068722A1
(en)
|
2009-12-01 |
2011-06-09 |
Noven Pharmaceuticals, Inc. |
Transdermal testosterone device and delivery
|
|
WO2011095314A2
(en)
|
2010-02-03 |
2011-08-11 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
|
WO2011112709A1
(en)
|
2010-03-09 |
2011-09-15 |
Elan Pharma International Limited |
Alcohol resistant enteric pharmaceutical compositions
|
|
US8481560B2
(en)
|
2010-04-02 |
2013-07-09 |
Alltranz Inc. |
Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
|
|
GB201006200D0
(en)
|
2010-04-14 |
2010-06-02 |
Ayanda As |
Composition
|
|
EP2560624B1
(en)
|
2010-04-23 |
2018-07-04 |
KemPharm, Inc. |
Therapeutic formulation for reduced drug side effects
|
|
FR2960775A1
(fr)
|
2010-06-07 |
2011-12-09 |
Ethypharm Sa |
Microgranules resistants au detournement
|
|
TWI501788B
(zh)
|
2010-09-02 |
2015-10-01 |
|
含陰離子聚合物之抗破碎劑型
|
|
EP2611425B1
(en)
|
2010-09-02 |
2014-07-02 |
Grünenthal GmbH |
Tamper resistant dosage form comprising an anionic polymer
|
|
CN103269688A
(zh)
|
2010-09-02 |
2013-08-28 |
格吕伦塔尔有限公司 |
包含无机盐的抗破碎剂型
|
|
US20120202838A1
(en)
|
2010-11-04 |
2012-08-09 |
Abbott Laboratories |
Drug formulations
|
|
US20120231083A1
(en)
|
2010-11-18 |
2012-09-13 |
The Board Of Trustees Of The University Of Illinois |
Sustained release cannabinoid medicaments
|
|
GB201020895D0
(en)
|
2010-12-09 |
2011-01-26 |
Euro Celtique Sa |
Dosage form
|
|
EP2654733B1
(en)
|
2010-12-23 |
2016-04-06 |
Purdue Pharma LP |
Tamper resistant solid oral dosage forms
|
|
BR112013021026A2
(pt)
|
2011-02-17 |
2016-10-11 |
Qrxpharma Ltd |
tecnologia para prevenção de abuso de formas de dosagem sólidas
|
|
CN103501773A
(zh)
|
2011-03-04 |
2014-01-08 |
格吕伦塔尔有限公司 |
用于口服给予的他喷他多含水药物制剂
|
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
|
CA2837077A1
(en)
|
2011-06-01 |
2012-12-06 |
Fmc Corporation |
Controlled release solid dose forms
|
|
EP2726065A4
(en)
|
2011-06-30 |
2014-11-26 |
Neos Therapeutics Lp |
MISS-BROKEN MEDICINAL PRODUCTS
|
|
HUE034710T2
(hu)
|
2011-07-29 |
2018-02-28 |
Gruenenthal Gmbh |
Visszaéléssel szemben ellenálló, azonnali hatóanyagfelszabadulást biztosító tabletta
|
|
ES2655900T3
(es)
|
2011-07-29 |
2018-02-22 |
Grünenthal GmbH |
Pastilla a prueba de manipulación que proporciona una liberación inmediata de un medicamento
|
|
FR2979242A1
(fr)
|
2011-08-29 |
2013-03-01 |
Sanofi Sa |
Comprime contre l'usage abusif, a base de paracetamol et d'oxycodone
|
|
CN103998025A
(zh)
|
2011-10-06 |
2014-08-20 |
格吕伦塔尔有限公司 |
包含阿片样物质激动剂和阿片样物质拮抗剂的防篡改口服药物剂型
|
|
AU2012338872B2
(en)
|
2011-11-17 |
2017-06-22 |
Grünenthal GmbH |
Tamper-resistant oral pharmaceutical dosage form comprising a pharmacologically active ingredient, an opioid antagonist and/or aversive agent, polyalkylene oxide and anionic polymer
|
|
US20150265536A1
(en)
|
2011-12-09 |
2015-09-24 |
Purdue Pharma L.P. |
Pharmaceutical dosage forms comprising poly(epsilon-caprolactone) and polyethylene oxide
|
|
EP2819657A1
(en)
|
2012-02-28 |
2015-01-07 |
Grünenthal GmbH |
Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant
|
|
WO2013127831A1
(en)
|
2012-02-28 |
2013-09-06 |
Grünenthal GmbH |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
|
EA028224B1
(ru)
|
2012-03-02 |
2017-10-31 |
Роудс Фармасьютикалз Л.П. |
Лекарственные формы немедленного высвобождения с защитой от несанкционированного применения
|
|
SI2838512T1
(sl)
|
2012-04-18 |
2018-11-30 |
Gruenenthal Gmbh |
Pred posegi in prehitrim sproščanjem odporna farmacevtska oblika odmerka
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
HUE035123T2
(en)
|
2012-05-11 |
2018-05-02 |
Gruenenthal Gmbh |
Thermoformed pharmaceutical dosage form with zinc
|
|
EP2906202A4
(en)
|
2012-10-15 |
2016-04-27 |
Isa Odidi |
DRUG FORMULATIONS FOR ORAL ADMINISTRATION
|
|
BR112015026549A2
(pt)
|
2013-05-29 |
2017-07-25 |
Gruenenthal Gmbh |
forma de dosagem à prova de violação contendo uma ou mais partículas
|
|
WO2014191396A1
(en)
|
2013-05-29 |
2014-12-04 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|
|
CA2817728A1
(en)
|
2013-05-31 |
2014-11-30 |
Pharmascience Inc. |
Abuse deterrent immediate release formulation
|
|
CN105682643B
(zh)
|
2013-07-12 |
2019-12-13 |
格吕伦塔尔有限公司 |
含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
|
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
|
WO2015065547A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
|
WO2015103379A1
(en)
|
2013-12-31 |
2015-07-09 |
Kashiv Pharma, Llc |
Abuse-resistant drug formulations
|